SCHEMBL17166556

COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(C#Cc3ccc(-c4cnc([C@@H]5[C@H]6CC[C@H](C6)N5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)ccc2[nH]1)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	CYP3A4	P08684	6/20	0.61

▸	CYP2C9	P11712	5/20	0.61

▸	NR1I2	O75469	2/20	0.61

▸	KCNH2	Q12809	2/20	0.61

▸	ABCB11	O95342	1/20	0.61

▸	OPRK1	P41145	1/20	0.61

▸	CYP1A2	P05177	2/20	0.57

▸	CYP2D6	P10635	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL2709696	0.92	CYP3A4 (0.73)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL18463064	0.92	CYP3A4 (0.73)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL19339830	0.92	CYP3A4 (0.73)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL205668	0.92	CYP3A4 (0.73)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL20055351	0.92	CYP3A4 (0.73)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL2706510	0.90	CYP3A4 (0.66)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL18462540	0.90	CYP3A4 (0.66)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL2709547	0.90	CYP3A4 (0.66)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL15368185	0.90	CYP3A4 (0.66)	CYP3A4CYP2C9NR1I2KCNH2ABCB11
SCHEMBL2706085	0.90	CYP3A4 (0.66)	CYP3A4CYP2C9NR1I2KCNH2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-9156818-B2	Hepatitis C virus inhibitors	ENANTA PHARMACEUTICALS, INC. (US)	2015-10-13	—	—	US	disclosed